1-6 of 6
Stephen Lim, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Efficacy and Safety of Ruxolitinib and Steroids for Treating Patients with Relapsed or Refractory Multiple Myeloma (RRMM)

James R. Berenson, MD, Noemi Silagan, MD, Jennifer To, BS, Tanya M. Spektor, PhD, Daisy Martinez, Armando J. Sanchez, Eli Forouzan, Regina Swift, Benjamin Eades, PharmD, Gary Schwartz, MD, Shahrooz Eshaghian, MD, Ralph V. Boccia, MD, Honghao Hank Yang, Stephen Lim, MD, Robert Vescio, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 36.
https://doi.org/10.1182/blood-2020-143005
Published: 2020
Journal Articles

A Phase 1 Trial of Ruxolitinib, Lenalidomide and Methylprednisolone for Patients with Relapsed/Refractory Multiple Myeloma (MM)

James R. Berenson, MD, Jennifer To, BS, Tanya M. Spektor, PhD, Daisy Martinez, Armando J. Sanchez, MBA, Carley Turner, CCRP, Regina Swift, Benjamin Eades, PharmD, Gary Schwartz, MD, Shahrooz Eshaghian, MD, Laura V. Stampleman, Robert A. Moss, MD, Youram Nassir, MD, Ravindranath Patel, MD, Alberto Bessudo, MD, Daniel Greenwald, MD, Ralph V. Boccia, MD, Stephen Lim, MD, Robert Vescio, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 1903.
https://doi.org/10.1182/blood-2019-131370
Published: 2019
Journal Articles

Patient Profile and Treatment Patterns in a Commercially Insured Population with Follicular Lymphoma

Nathan H Fowler, MD, Yanni Hao, PhD, Stephen Lim, MD, Guifang Chen, PhD, Frank Li, PhD, Steve Arcona, PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 5880.
https://doi.org/10.1182/blood-2019-127237
Published: 2019
Journal Articles

A Phase 1 Trial of Ruxolitinib, Lenalidomide and Methylprednisolone for Relapsed/Refractory Multiple Myeloma Patients

James R Berenson, MD, To Jennifer, BS, Tanya M. Spektor, PhD, Carley Turner, CCRP, Regina Swift, Benjamin Eades, PharmD, Gary Schwartz, MD, Shahrooz Eshaghian, MD, Laura V. Stampleman, Robert A. Moss, MD, Alberto Bessudo, MD, Ravindranath Patel, MD, Stephen Lim, MD, Robert Vescio, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 1988.
https://doi.org/10.1182/blood-2018-99-119274
Published: 2018
Journal Articles

Safety of PK-Guided IV Bu Cy VP-16 Preparative Regimen Prior to Autologous Hematopoietic Stem Cell Transplantation for Lymphoma: Findings From a Multi-Center Phase II Study in North America

Luciano J Costa, MD, PhD, Michael Lill, M.D., Rosa F. Yeh, PharmD, Robert K Stuart, MD, Stephen Lim, MD, Edmund K. Waller, MD, PhD, Tsiporah B. Shore, MD, Michael Craig, MD, Cesar O. Freytes, MD, Thomas C. Shea, MD, Tulio E. Rodriguez, MD, Ian W. Flinn, MD, PhD, Terrance Comeau, MD, FRCPC, Michael A. Pulsipher, MD, Isabelle Bence-Bruckler, MD, FRCPC, Pierre Laneuville, MD, Philip Bierman, MD, Andy I. Chen, MD, PhD, Louie H. Yu, BS, Shiva Patil, PhD, Yiping Sun, PhD, Elizabeth Armstrong, MS, Angela Smith, MS, PA, Agnes Elekes, MD, Kazunobu Kato, MD, PhD, William Vaughan, MD
Journal: Blood
Blood (2012) 120 (21): 813.
https://doi.org/10.1182/blood.V120.21.813.813
Published: 2012
Journal Articles

Stem Cell Transplantation for Relapsed and Refractory Burkitt Lymphoma.

Steven Kwon, M.D., Amir Steinberg, MD, Catherine Bresee, M.S., Mercedes Franco, Angela M. Lopez, MD, Stephen Lim, MD, Michael Lill, M.D.
Journal: Blood
Blood (2010) 116 (21): 4589.
https://doi.org/10.1182/blood.V116.21.4589.4589
Published: 2010